Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hydroponics Company (now THC Global Group) operates a large-scale pharmaceutical biomanufacturing facility in Queensland, Australia, capable of producing high-purity cannabinoid active pharmaceutical ingredients and finished medicinal cannabis products for domestic and export markets; it is revenue-generating and positioned as a leading Australian medicinal cannabis producer, but detailed clinical trial results are not publicly highlighted, reflecting a focus on supplying GMP-grade cannabis APIs and products rather than proprietary, trial-based pharmaceuticals.[2][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on THC Global Group.